The structural basis for induction of VanB resistanceDONG, Steven D; OBERTHUR, Markus; LOSEY, Heather C et al.Journal of the American Chemical Society. 2002, Vol 124, Num 31, pp 9064-9065, issn 0002-7863Article

Linear immunoglobulin A disease and vancomycin: letter in replyINGEN-HOUSZ-ORO, S; VALEYRIE-ALLANORE, L; CHANAL, J et al.British journal of dermatology (1951). 2014, Vol 171, Num 6, pp 1602-1604, issn 0007-0963, 3 p.Article

Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patientsBARRIGA, F. J; VARAS, M; POTIN, M et al.Medical and pediatric oncology. 1997, Vol 28, Num 3, pp 196-200, issn 0098-1532Conference Paper

The role of vancomycin in the treatment paradigmSTEVENS, Dennis L.Clinical infectious diseases. 2006, Vol 42, issn 1058-4838, S51-S57, SUP1Article

Antibiotic optimization via in vitro glycorandomizationXUN FU; ALBERMANN, Christoph; JIQING JIANG et al.Nature biotechnology. 2003, Vol 21, Num 12, pp 1467-1469, issn 1087-0156, 3 p.Article

Optimizing initial vancomycin dosing in burn patientsELLIGSEN, Marion; WALKER, Sandra A. N; WALKER, Scott E et al.Burns. 2011, Vol 37, Num 3, pp 406-414, issn 0305-4179, 9 p.Article

Vancomycin: We Can't Get There From HerePATEL, Nimish; PAI, Manjunath P; RODVOLD, Keith A et al.Clinical infectious diseases. 2011, Vol 52, Num 8, pp 969-974, issn 1058-4838, 6 p.Article

Separation and Determination of Clenbuterol by HPLC Using a Vancomycin Chiral Stationary PhaseMOSTAFA, Gamal A. E; HEFNAWY, Mohammed M; EL-MAJED, Abdulrahman et al.Journal of AOAC International. 2009, Vol 92, Num 3, pp 824-829, issn 1060-3271, 6 p.Article

Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococciBOURGEOIS, Ingrid; PESTEL-CARON, Martine; LEMELAND, Jean-Francois et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 2, pp 740-743, issn 0066-4804, 4 p.Article

Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimersGRIFFIN, John H; LINSELL, Martin S; JENKINS, Thomas E et al.Journal of the American Chemical Society. 2003, Vol 125, Num 21, pp 6517-6531, issn 0002-7863, 15 p.Article

Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?NEELY, Michael N; YOUN, Gilmer; JONES, Brenda et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 309-316, issn 0066-4804, 8 p.Article

A successful challenge in a patient with vancomycin-induced linear IgA dermatosisJOSHI, Sunil; SCOTT, Glynis; LOONEY, R. John et al.Annals of allergy, asthma, & immunology. 2004, Vol 93, Num 1, pp 101-103, issn 1081-1206, 3 p.Article

Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the InnovatorVESGA, Omar; AGUDELO, Maria; SALAZAR, Beatriz E et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 8, pp 3271-3279, issn 0066-4804, 9 p.Article

Vancomycin : Understanding Its Past and Preserving Its FutureLEVINE, Donald P.Southern medical journal (Birmingham). 2008, Vol 101, Num 3, pp 284-291, issn 0038-4348, 8 p.Article

Transplacental transfer of vancomycin and telavancinNANOVSKAYA, Tatiana; PATRIKEEVA, Svetlana; YING ZHAN et al.American journal of obstetrics and gynecology. 2012, Vol 207, Num 4, pp 331-332, issn 0002-9378, 2 p.Conference Paper

Initial dosing of vancomycin in critically ill patientsKEES, Martin G; VÖGELER, Stephan; HILPERT, Justus W et al.International journal of antimicrobial agents (Print). 2011, Vol 38, Num 1, pp 91-92, issn 0924-8579, 2 p.Article

Lack of Health Insurance Coverage for Oral Vancomycin: It's Time to Tackle the Elephant in the RoomSTUDEMEISTER, Alex.Clinical infectious diseases. 2011, Vol 52, Num 5, pp 691-692, issn 1058-4838, 2 p.Article

Falsely elevated vancomycin plasma concentrations sampled from central venous implantable catheters (portacaths)WRIGHT, Daniel F. B; AL-SALLAMI, Hesham S; JACKSON, Pamela M et al.British journal of clinical pharmacology. 2010, Vol 70, Num 5, pp 769-772, issn 0306-5251, 4 p.Article

Analysis of the Mobilization Functions of the Vancomycin Resistance Transposon Tn1549, a Member of a New Family of Conjugative ElementsTSVETKOVA, Krassimira; MARVAUD, Jean-Christophe; LAMBERT, Thierry et al.Journal of bacteriology. 2010, Vol 192, Num 3, pp 702-713, issn 0021-9193, 12 p.Article

Focal injection of vancomycin combined with surgical debridement-dermatoplasty in the treatment of pseudo-epitheliomatous granulomaJIANG, Du-Yin; FU, Xiao-Bing; ZONG, Xian-Lei et al.Burns. 2010, Vol 36, Num 4, pp 552-557, issn 0305-4179, 6 p.Article

Isolation of VanA-Type Vancomycin-Resistant Enterococcus Strains from Domestic Poultry Products with Enrichment by Incubation in Buffered Peptone Water at 42°CHARADA, Tetsuya; KANKI, Masashi; KAWAI, Takao et al.Applied and environmental microbiology (Print). 2010, Vol 76, Num 15, pp 5317-5320, issn 0099-2240, 4 p.Article

Streptogramin resistance patterns and virulence determinants in vancomycin-susceptible enterococci isolated from multi-component deli saladsCHRISTENSEN, E. A; JOHO, K; MATTHEWS, K. R et al.Journal of applied microbiology (Print). 2008, Vol 104, Num 5, pp 1260-1265, issn 1364-5072, 6 p.Article

Predictability of vancomycin pharmacokinetics in neonatesALLEGAERT, K; VAN DEN ANKER, J. N.European journal of clinical microbiology & infectious diseases (Print). 2007, Vol 26, Num 11, pp 847-848, issn 0934-9723, 2 p.Article

Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalisMARRA, Alexandre R; MAJOR, Yvette; EDMOND, Michael B et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 5, pp 1915-1916, issn 0095-1137, 2 p.Article

In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(ε-caprolactone) microparticlesLE RAY, Anne-Marie; GAUTIER, Hélène; LATY, Marie-Katel et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 7, pp 3025-3027, issn 0066-4804, 3 p.Article